Article Details

Dexamethasone Raises VTE Risk in COVID-19 Cases with Sickle Cell - HCPLive

Retrieved on: 2024-12-04 20:36:52

Tags for this article:

Click the tags to see associated articles and topics

Dexamethasone Raises VTE Risk in COVID-19 Cases with Sickle Cell - HCPLive. View article details on hiswai:

Excerpt

Dexamethasone treatment was linked to worse clinical outcomes in patients with sickle cell disease hospitalized for COVID-19.

Article found on: www.hcplive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo